Chambers Michael Andrew 4
4 · Sarepta Therapeutics, Inc. · Filed Sep 15, 2022
Insider Transaction Report
Form 4
Chambers Michael Andrew
Director
Transactions
- Purchase
Common Stock
2022-09-14$105.16/sh+6,250$657,250→ 108,178 total - Purchase
Common Stock
2022-09-14$103.87/sh+20,744$2,154,679→ 71,822 total - Purchase
Common Stock
2022-09-14$104.67/sh+30,106$3,151,195→ 101,928 total
Holdings
- 75,194(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $103.06 to $104.05, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $104.065 to $105.05, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $105.085 to $105.40, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.